Sanofi reaffirms target to deliver over $10.9 billion in annual vaccine sales by 2030

Reuters

Published Jun 29, 2023 06:51

(Reuters) - French drugmaker Sanofi (EPA:SASY) on Thursday reaffirmed its ambition to deliver more than 10 billion euros ($10.89 billion)in annual vaccines sales by 2030, driven by core franchises of influenza, meningitis, and pediatric vaccines, with the addition of RSV.